Correlation Between RPBio and ICD
Can any of the company-specific risk be diversified away by investing in both RPBio and ICD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RPBio and ICD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RPBio Inc and ICD Co, you can compare the effects of market volatilities on RPBio and ICD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RPBio with a short position of ICD. Check out your portfolio center. Please also check ongoing floating volatility patterns of RPBio and ICD.
Diversification Opportunities for RPBio and ICD
Very poor diversification
The 3 months correlation between RPBio and ICD is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding RPBio Inc and ICD Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICD Co and RPBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RPBio Inc are associated (or correlated) with ICD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICD Co has no effect on the direction of RPBio i.e., RPBio and ICD go up and down completely randomly.
Pair Corralation between RPBio and ICD
Assuming the 90 days trading horizon RPBio Inc is expected to generate 1.0 times more return on investment than ICD. However, RPBio is 1.0 times more volatile than ICD Co. It trades about -0.13 of its potential returns per unit of risk. ICD Co is currently generating about -0.16 per unit of risk. If you would invest 666,000 in RPBio Inc on September 3, 2024 and sell it today you would lose (126,000) from holding RPBio Inc or give up 18.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
RPBio Inc vs. ICD Co
Performance |
Timeline |
RPBio Inc |
ICD Co |
RPBio and ICD Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RPBio and ICD
The main advantage of trading using opposite RPBio and ICD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RPBio position performs unexpectedly, ICD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICD will offset losses from the drop in ICD's long position.RPBio vs. PJ Metal Co | RPBio vs. Wave Electronics Co | RPBio vs. Youngsin Metal Industrial | RPBio vs. Daeduck Electronics Co |
ICD vs. SFA Engineering | ICD vs. APS Holdings | ICD vs. Soulbrain Holdings Co | ICD vs. JUSUNG ENGINEERING Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Managers Screen money managers from public funds and ETFs managed around the world |